ActaStim-S promotes healing and uses a mobile app to allow patients to track their progress, according to an Aug. 18 news release from the devicemaker. The patent focuses on ensuring connectivity does not interfere with the device’s ease of use.
“Spinal fusion is a healing process, often characterized as a race to achieve solid fusion before failure of the implanted hardware,” Theragen CEO Chris McAuliffe said in the release. “That’s why we’ve taken a user-centric approach, designing a more wearable device that also offers a digital health component that gives patients the unique opportunity to engage in, follow and truly impact their own recovery.”
